Creating a database of healthy individuals using brain imaging techniques
Creation of a Database of Healthy Subjects With 18FDG PET Brain Imaging as Part of the MOBILE Project (Multimodal Whole-Brain Imaging in Epilepsy)
This study is testing brain imaging techniques on healthy adults to help build a database that will improve our understanding of how the brain works.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Assistance Publique Hopitaux De Marseille Academic / other |
| Locations | 1 site (Marseille) |
| Trial ID | NCT06976788 on ClinicalTrials.gov |
What this trial studies
The MOBILE project aims to characterize brain structure and function in both healthy subjects and patients with epilepsy through a multimodal approach that includes neuroimaging and electrophysiology. This specific application focuses on performing 18F-FDG PET imaging on 30 healthy adult participants aged 18 to 65. The data collected will contribute to a larger database that will be accessible to the scientific community, enhancing understanding of brain development and function. The study is part of a broader European collaboration under the Human Brain Project.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy adults aged 18 to 65 with no significant medical history or psychiatric disorders.
Not a fit: Patients with existing neurological conditions or those who are pregnant or breastfeeding will not benefit from this study.
Why it matters
Potential benefit: If successful, this project could provide valuable insights into brain health and development, aiding in the understanding and treatment of epilepsy.
How similar studies have performed: Other studies utilizing multimodal imaging approaches have shown promise in understanding brain function, suggesting potential success for this novel application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * \- Female or male, over 18 and under 65 years of age. * Subject free of any general illness, psychiatric disorders or infectious, inflammatory, tumoral, vascular, degenerative or traumatic pathology of the central nervous system, as determined on examination, * Subject not receiving chronic treatment, particularly psychotropic, * Subject with no history of alcoholism or drug addiction, * Subject with no contraindications to PET scintigraphic exploration (pregnancy and breast-feeding), * Subject with social security coverage, * Subject having read, understood and signed an informed consent form. Exclusion Criteria: * \- Minors, * Pregnant or breast-feeding women, * Women of childbearing age without contraception, * Subjects presenting a contraindication to PET scintigraphic exploration, * adult subject to a legal protection measure, as provided for in L.1121-6 to L.1121-8 of the French Public Health Code.
Where this trial is running
Marseille
- Hopital de la Timone — Marseille, France (Recruiting)
Study contacts
- Study coordinator: Eric GUEDJ, MD
- Email: eric.guedj@ap-hm.fr
- Phone: 0491386595
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.